Explore the words cloud of the MIB project. It provides you a very rough idea of what is the project "MIB" about.
The following table provides information about the project.
DANMARKS TEKNISKE UNIVERSITET
|Coordinator Country||Denmark [DK]|
|Total cost||5˙983˙807 €|
|EC max contribution||5˙983˙807 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2016-01-01 to 2020-12-31|
Take a look of project's partnership.
|1||DANMARKS TEKNISKE UNIVERSITET||DK (KGS LYNGBY)||coordinator||829˙254.00|
|2||MEDIZINISCHE UNIVERSITAET WIEN||AT (WIEN)||participant||689˙078.00|
|3||FORSCHUNGSVERBUND BERLIN EV||DE (BERLIN)||participant||669˙582.00|
|4||HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH||DE (NEUHERBERG)||participant||655˙046.00|
|5||LEIBNIZ-INSTITUT FUER PHOTONISCHE TECHNOLOGIEN E.V.||DE (JENA)||participant||653˙875.00|
|6||M-SQUARED LASERS LIMITED||UK (GLASGOW)||participant||512˙500.00|
|7||2M ENGINEERING LIMITED||UK (FOLKSTONE)||participant||502˙102.00|
|8||REGION HOVEDSTADEN||DK (HILLEROD)||participant||479˙081.00|
|9||Blazejewski MEDI-TECH GMBH||DE (Sexau)||participant||432˙812.00|
|10||GRINTECH GMBH||DE (Jena)||participant||365˙475.00|
|11||ALBERT-LUDWIGS-UNIVERSITAET FREIBURG||DE (FREIBURG)||participant||195˙000.00|
Bladder cancer is among the most expensive diseases in oncology in terms of treatment costs; each procedure requires days of hospitalisation and recurrence rates are high. Current unmet clinical needs can be addressed by optical methods due to the combination of non-invasive and real-time capture of unprecedented biomedical information. The MIB objective is to provide robust, easy-to-use, cost-effective optical methods with superior sensitivity and specificity to enable a step-change in point-of-care diagnostics of bladder cancer. The concept relies on combining optical methods (optical coherence tomography, multi-spectral opto-acoustic tomography, shifted excitation Raman difference spectroscopy, and multiphoton microscopy) providing structural, biochemical and functional information. The hypothesis is that such combination enables in situ diagnosis of bladder cancer with superior sensitivity and specificity due to unprecedented combined anatomic, biochemical and molecular tissue information. The step-change is that this hybrid concept is provided endoscopically for in vivo clinical use. The project relies on development of new light sources, high-speed imaging systems, unique imaging fibre bundles, and endoscopes, combined and applied clinically. The consortium comprises world-leading academic organisations in a strong partnership with innovative SMEs and clinical end-users. Through commercialization of this novel imaging platform, MIB is expected to reinforce leading market positions in medical devices and healthcare for the SMEs in areas where European industry is already strong. The impact is that improved diagnostic procedures facilitate earlier onset of effective treatment, thus recurrence and follow-up procedures would be reduced by 10%, i.e., reducing costs. Using MIB technology, healthcare cost savings in the order of 360M€ are expected for the whole EU. Equally important, prognosis and patient quality of life would improve drastically.
|Project Website||Demonstrators, pilots, prototypes||2020-04-07 20:27:06|
Take a look to the deliverables list in detail: detailed list of MIB deliverables.
|year||authors and title||journal||last update|
Fabian Placzek, Eliana Cordero Bautista, Simon Kretschmer, Lara M. Wurster, Florian Knorr, Gerardo GonzÃ¡lez-Cerdas, Mikael T. ErkkilÃ¤, Patrick Stein, Ã‡aÄŸlar Ataman, Gregers G. Hermann, Karin Mogensen, Thomas Hasselager, Peter E. Andersen, Hans Zappe, JÃ¼rgen Popp, Wolfgang Drexler, Rainer A. Leitgeb, Iwan W. Schie
Morpho-molecular ex vivo detection and grading of non-muscle-invasive bladder cancer using forward imaging probe based multimodal optical coherence tomography and Raman spectroscopy
published pages: , ISSN: 0003-2654, DOI: 10.1039/c9an01911a
Martin Maiwald, Bernd Sumpf, GÃ¼nther TrÃ¤nkle
Rapid and adjustable shifted excitation Raman difference spectroscopy using a dual-wavelength diode laser at 785Â nm
published pages: , ISSN: 0377-0486, DOI: 10.1002/jrs.5456
|Journal of Raman Spectroscopy||2020-04-07|
Daniela Bovenkamp, Ryan Sentosa, Elisabet Rank, Mikael ErkkilÃ¤, Fabian Placzek, Jeremias PÃ¼ls, Wolfgang Drexler, Rainer Leitgeb, Nathalie Garstka, Shahrokh Shariat, Clara Stiebing, Iwan Schie, JÃ¼rgen Popp, Marco Andreana, Angelika Unterhuber
Combination of High-Resolution Optical Coherence Tomography and Raman Spectroscopy for Improved Staging and Grading in Bladder Cancer
published pages: 2371, ISSN: 2076-3417, DOI: 10.3390/app8122371
|Applied Sciences 8/12||2020-04-07|
Dominik Marti, Rikke N. Aasbjerg, Peter E. Andersen, Anders K. Hansen
MCmatlab: an open-source, user-friendly, MATLAB-integrated three-dimensional Monte Carlo light transport solver with heat diffusion and tissue damage
published pages: 1, ISSN: 1083-3668, DOI: 10.1117/1.jbo.23.12.121622
|Journal of Biomedical Optics 23/12||2020-04-07|
Lara M. Wurster, Ronak N. Shah, Fabian Placzek, Simon Kretschmer, Michael Niederleithner, Laurin Ginner, Jason Ensher, Michael P. Minneman, Erich E. Hoover, Hans Zappe, Wolfgang Drexler, Rainer A. Leitgeb, Ã‡aÄŸlar Ataman
Endoscopic optical coherence tomography angiography using a forward imaging piezo scanner probe
published pages: e201800382, ISSN: 1864-063X, DOI: 10.1002/jbio.201800382
|Journal of Biophotonics||2020-04-07|
In-vivo Raman spectroscopy: from basics to applications
published pages: 1, ISSN: 1083-3668, DOI: 10.1117/1.jbo.23.7.071210
|Journal of Biomedical Optics 23/07||2020-04-07|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIB" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MIB" are provided by the European Opendata Portal: CORDIS opendata.
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
ENDOSCAPE, a clinically applicable non-viral gene delivery technologyRead More
Childhood Leukemia: Overcoming distance between South America and Europe RegionsRead More